Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Melanoma Skin Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT06751524
What this trial is testing

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Who this might be right for
Colorectal Cancer (CRC)Pancreatic CancerNon-Small Cell Lung Cancer (NSCLC)+5 more
Agenus Inc.
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Ended earlyNCT00039091
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+11 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Large-scale testing (Phase 3)Looking for participantsNCT06585410
What this trial is testing

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals 369
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Not applicableStudy completedNCT02760225
What this trial is testing

Pembrolizumab-PET Imaging

Who this might be right for
MelanomaNon-small Cell Lung Cancer
University Medical Center Groningen 18
Testing effectiveness (Phase 2)Study completedNCT02308020
What this trial is testing

Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

Who this might be right for
Breast CancerNon-small Cell Lung CancerMelanoma+1 more
Eli Lilly and Company 162
Early research (Phase 1)Ended earlyNCT06448364
What this trial is testing

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+2 more
Pfizer 4
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT01831726
What this trial is testing

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

Who this might be right for
Tumor Pathway Activations Inhibited by Dovitinib
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05688280
What this trial is testing

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

Who this might be right for
Metastatic Solid TumorColon CancerNonsmall Cell Lung Cancer+1 more
Immunophotonics, Inc. 42
Testing effectiveness (Phase 2)WithdrawnNCT00769990
What this trial is testing

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Who this might be right for
Breast CancerKidney CancerLung Cancer+4 more
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Testing effectiveness (Phase 2)UnknownNCT04929535
What this trial is testing

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma of Skin Differentiated
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 51
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Next Page